Tuesday, April 9, 2019, 1:00 – 2:00 p.m. ET
Rajesh Pahwa, MD
Laverne and Joyce Rider Professor of Neurology
Chief, Parkinson and Movement Disorder Division
Director, Parkinson’s Foundation Center of Excellence
University of Kansas Medical Center
Learning Objectives: At the conclusion of this webinar, the participants will:
- Be familiar with new treatment options in the next 2 years
- Understand who would be the best candidates for the new therapies
Rajesh Pahwa, MD
Dr. Pahwa is the Laverne and Joyce Rider Professor of Neurology at the University of Kansas Medical Center. He is also Chief, Parkinson and Movement Disorder Division and Director of Parkinson Foundation Center of Excellence at the University of Kansas Medical Center, Kansas City, Kansas.
Dr. Pahwa received his medical degree at Seth G.S. Medical College, University of Bombay, India. He completed an internship in medicine at Baylor College of Medicine followed by a residency in Neurology at Baylor College of Medicine, Houston, Texas. He then completed a fellowship in movement disorders at the University of Kansas Medical Center. Dr. Pahwa is a Diplomate of the American Board of Psychiatry and Neurology.
Dr. Pahwa's research interests are centered around the various aspects of Parkinson's disease and essential tremor. He is currently involved in studies related to medical and surgical forms of therapies for Parkinson's disease and essential tremor. Dr. Pahwa has published more than 200 peer-reviewed articles, approximately 50 chapters and over 200 abstracts in leading neurology and movement disorder journals. He has conducted more than 100 clinical trials related to Parkinson's disease and other movement disorders. He is the co-editor of "Handbook of Parkinson's Disease", 3rd and 4th editions; "Therapy of Parkinson's Disease", 3rd edition; and "Handbook of Essential Tremor and other Tremor Disorders".